Gemcitabine Plus Capecitabine More Effective for Treatment of Pancreatic Cancer Than Gemcitabine Alone
Gemcitabine plus capecitabine improves survival for patients with pancreatic cancer
All articles by John Eckman
Aspirin Associated With Improved Survival for Patients With Colorectal Cancer
Aspirin exposure is associated with improved CRC-specific survival.
Cediranib Alone Linked to Higher PFS Than in Conjunction With Lenalidomide for Differentiated Thyroid Cancer (DTC)
Cediranib in conjunction with lenalidomide is evidently not a more effective therapy for patients with advanced differentiated thyroid cancer (DTC).
Idelalisib Shows High Likelihood of Hepatotoxicity, Particularly Among Younger Patients With CLL
Drugs such as idelalisib may frequently cause immune-mediated hepatotoxicity in chronic lymphocytic leukemia (CLL).
Pembrolizumab Should Be Tested Further as Treatment for Advanced Head And Neck Cancers
Pembrolizumab may be an effective treatment for patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Higher Dose of Pembrolizumab Not Evidently Beneficial for Non-small Cell Lung Cancer (NSCLC)
Previously treated patients with advanced non-small-cell lung cancer (NSCLC) ought to receive pembrolizumab.
Sex Discrepancy May Explain Lower OS in Women With Advanced Bladder Cancer
Poor OS in women with bladder cancer may be attributable to the lower frequency of women being treated with systemic chemotherapy.
- Loading...
Loading...
Next post in Urologic Cancers
Loading... 
Loading...